Management of prostate cancer after prostatectomy - Treating the patient, not the PSA

被引:20
作者
Scher, HI [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Genitourinary Oncol Serv, New York, NY 10021 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 17期
关键词
D O I
10.1001/jama.281.17.1642
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1642 / 1645
页数:4
相关论文
共 29 条
[1]  
Adib RS, 1997, BRIT J UROL, V79, P235
[2]   Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer [J].
Bauer, JJ ;
Connelly, RR ;
Seterhenn, IA ;
Deausen, J ;
Srivastava, S ;
McLeod, DG ;
Moul, JW .
JOURNAL OF UROLOGY, 1998, 159 (03) :929-933
[3]   Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin [J].
Bolla, M ;
Gonzalez, D ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Gil, T ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :295-300
[4]  
Byar D P, 1988, NCI Monogr, P165
[5]   MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
DODDS, KM ;
COPLEN, DE ;
YUAN, JJJ ;
PETROS, JA ;
ANDRIOLE, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161
[6]   What should men know about prostate-specific antigen screening before giving informed consent? [J].
Chan, ECY ;
Sulmasy, DP .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (04) :266-274
[7]   A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA [J].
CRAWFORD, ED ;
EISENBERGER, MA ;
MCLEOD, DG ;
SPAULDING, JT ;
BENSON, R ;
DORR, FA ;
BLUMENSTEIN, BA ;
DAVIS, MA ;
GOODMAN, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) :419-424
[8]   GOSERELIN ACETATE AND FLUTAMIDE VERSUS BILATERAL ORCHIECTOMY - A PHASE-III EORTC TRIAL (30853) [J].
DENIS, LJ ;
DEMOURA, JLC ;
BONO, A ;
SYLVESTER, R ;
WHELAN, P ;
NEWLING, D ;
DEPAUW, M ;
FLANIGAN, RC .
UROLOGY, 1993, 42 (02) :119-130
[9]   Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer [J].
Dillioglugil, O ;
Leibman, BD ;
Kattan, MW ;
SealeHawkins, C ;
Wheeler, TM ;
Scardino, PT .
UROLOGY, 1997, 50 (01) :93-99
[10]   Bilateral orchiectomy with or without flutamide for metastatic prostate cancer [J].
Eisenberger, MA ;
Blumenstein, BA ;
Crawford, ED ;
Miller, G ;
McLeod, DG ;
Loehrer, PJ ;
Wilding, G ;
Sears, K ;
Culkin, DJ ;
Thompson, IM ;
Bueschen, AJ ;
Lowe, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) :1036-1042